2024 annual financial data
Altimmune 2024 Operating margin
Altimmune 2024 operating margin with verified reported values.
Direct answer
Operating margin was -515,860%.
Operating income was -103,172,000 USD and net income was -95,059,000 USD.
Operating cash flow was -79,848,000 USD.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,000 USD
- Operating income
- -103,172,000 USD
- Net income
- -95,059,000 USD
- Operating cash flow
- -79,848,000 USD